Item 9 Labs Corp (INLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,431 | -2,025 | -396 | -4,741 | -2,765 |
| Depreciation Amortization | 58 | 26 | 3 | 1,966 | 1,373 |
| Accounts receivable | 1 | N/A | N/A | 3 | 3 |
| Accounts payable and accrued liabilities | 89 | 38 | 40 | 20 | 29 |
| Other Working Capital | 226 | 60 | 51 | 190 | 170 |
| Other Operating Activity | 1,797 | 1,663 | 245 | 1,821 | 646 |
| Operating Cash Flow | $-261 | $-238 | $-58 | $-741 | $-545 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -7 | -7 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $-7 | $-7 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 200 | 200 | N/A | 498 | 498 |
| Debt Repayment | -36 | -24 | -12 | -23 | -23 |
| Common Stock Issued | 63 | 63 | 54 | 271 | 69 |
| Financing Cash Flow | $228 | $240 | $43 | $747 | $544 |
| Beginning Cash Position | 42 | 42 | 42 | 43 | 43 |
| End Cash Position | 9 | 44 | 27 | 42 | 35 |
| Net Cash Flow | $-33 | $2 | $-15 | $-1 | $-7 |
| Free Cash Flow | |||||
| Operating Cash Flow | -261 | -238 | -58 | -741 | -545 |
| Capital Expenditure | N/A | N/A | N/A | -7 | -7 |
| Free Cash Flow | -261 | -238 | -58 | -748 | -551 |